In this study, we present evidence that both drugs can induce an increase in the expression of differentiation markers and morphological changes associated with maturation in samples isolated from patients with AML, and these effects do not correlate with either FAB classification or mutational status of NPM1 and FLT3-ITD. Here, NPM1 is linked to acute myeloid leukemia.